Frank Torti Net Worth & Insider Trades

Frank Torti - Director, Immunovant, Inc

As of September 29, 2022

What is Frank Torti's Net Worth?

The current estimated net worth of Immunovant, Inc's Director, Frank Torti, is estimated to be about $117.86K . Frank Torti owns about 393,358 units of Immunovant, Inc common stock. In the last 3 years at Immunovant, Inc, Frank Torti has sold an estimated value of $0 worth.

What is Frank Torti's Past Insider Trading?

Frank Torti's largest purchase order was 20,000 units , worth over $116.2K on September 29, 2022. In total, Frank Torti has made about 6 transactions over 3 years of their time at Immunovant, Inc. Frank Torti usually trades in December, August, March, May, September and January, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Frank Torti's' Mailing Address?

  • Mailing address is 2855 Sand Hill Road Menlo Park CA 94025 CA

Immunovant, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Peter Salzmann, M.D., M.B.A. 2020 $ 567,000 $ 311,850 $ 3,252,500 $ 11,104,950 $ $ 139,004 $ 15,375,304
Peter Salzmann, M.D., M.B.A. 2019 $361,010 $500,000 - $7,721,344 $224,480 - $8,806,834
Pamela Yanchik Connealy, M.B.A. 2020 $393,000 $157,200 $785,400 $4,258,363 - $8,742 $5,602,705
Pamela Yanchik Connealy, M.B.A. 2019 $147,618 - - $2,437,762 $61,233 $129,321 $2,775,934
Julia G. Butchko, Ph.D. 2020 $372,000 $148,800 $926,500 $6,384,856 - $10,201 $7,842,357
Michael J. Elliott, 2020 $242,425 $96,000 $1,659,200 $14,229,311 - $9,695 $16,236,631
Rita Jain, M.D. 2020 $101,137 $38,526 $2,703,005 $10,666,997 - $3,319 $13,512,984
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000083/imvt-20210331defproxy.htm

What are Immunovant, Inc's Past Insider Trades?

Immunovant, Inc's most recent insider trade came on February 3, 2023 by William L Macias who sold 537 units worth $9.79K . In the last 3 years, insiders at Immunovant, Inc have sold an estimated value of $4.22M and bought an estimated value of $399.92M worth of shares. Insider trading is most common in August, with the busiest year in 2022. The most active traders at the company are Julia G Butchko, Chief Dev. & Tech. Officer,  Peter Salzmann, Chief Executive Officer,  and William L Macias, Chief Medical Officer .

Immunovant, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1